In support of the mutator phenotype hypothesis [67], mutations in MLL3 seem to be acquired at a later stage of tumour development (passenger mutations) and are not initiators of tumour formation as opposed to driver mutations like KRAS G12V/D [68]. This evidence concerns the gene KMT2C and neoplasm.